Filana Therapeutics, Inc. (FLNA)
0.8283
-0.03
(-3.42%)
USD |
NASDAQ |
Sep 03, 16:00
0.847
+0.02
(+2.26%)
After-Hours: 07:53
Filana Therapeutics Cash from Investing (Quarterly) : -0.021M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.021M |
| March 31, 2026 | 0.00 |
| December 31, 2025 | -0.501M |
| September 30, 2025 | -0.08M |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | -0.057M |
| September 30, 2024 | -0.017M |
| June 30, 2024 | -0.029M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | -0.041M |
| September 30, 2023 | -0.022M |
| June 30, 2023 | 0.006M |
| March 31, 2023 | -0.357M |
| December 31, 2022 | 0.335M |
| September 30, 2022 | -1.156M |
| June 30, 2022 | -1.466M |
| March 31, 2022 | -0.425M |
| December 31, 2021 | -0.10M |
| September 30, 2021 | -22.04M |
| June 30, 2021 | -0.073M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.26M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.10M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | -0.018M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 2.101M |
| December 31, 2016 | -1.544M |
| September 30, 2016 | -0.625M |
| June 30, 2016 | 1.50M |
| March 31, 2016 | -1.497M |
| December 31, 2015 | 0.90M |
| September 30, 2015 | 0.051M |
| June 30, 2015 | 1.051M |
| March 31, 2015 | -2.194M |
| December 31, 2014 | 1.101M |
| September 30, 2014 | -0.851M |
| June 30, 2014 | 1.001M |
| March 31, 2014 | -0.079M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| CorMedix, Inc. | -0.561M |
| Eloxx Pharmaceuticals, Inc. | 0.00 |
| Cannabis Global, Inc. | 0.00 |
| Breakthrough Chemistry, Inc. | 0.00 |
| BioStem Technologies, Inc. | -0.0561M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.855M |
| Cash from Financing (Quarterly) | -0.016M |
| Free Cash Flow | -29.30M |
| Free Cash Flow Per Share (Quarterly) | -0.0802 |
| Free Cash Flow to Equity (Quarterly) | -3.876M |
| Free Cash Flow to Firm (Quarterly) | -3.876M |
| Free Cash Flow Yield | -73.24% |